AI-guided monitoring to detect and treat liver cancer recurrence early
Part of Cancer, Digestive system clinical trials.
This study tests whether an artificial intelligence system can help doctors find and treat liver cancer if it comes back after your first surgery or ablation. It focuses on early detection and providing another curative treatment if a recurrence is found.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with hepatocellular carcinoma (the most common type of liver cancer) for the first time.
- You have already completed a curative treatment: either surgery to remove the tumor (with clear margins) or thermal ablation (using heat to destroy the tumor).
- A CT or MRI scan taken 4 to 8 weeks after your treatment showed no remaining or new cancer.
- Your liver function is generally good (classified as Child-Pugh A) and you are physically active (ECOG status 0 or 1).
- You are willing and able to have repeated CT or MRI scans and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
This study uses digital scans of your tumor tissue and CT/MRI images to build a computer model that helps predict whether you might need extra treatment (adjuvant therapy) after liver cancer surgery. The goal is to use your own tissue and scan data to personalize follow-up care.
This study uses artificial intelligence to look at tumor samples and MRI scans from people with advanced liver cancer to help choose the best treatment. It aims to make treatment more personalized and effective.
This trial uses a computer program to help doctors find signs of microscopic tumor spread in blood vessels (microvascular invasion) from liver cancer images. It aims to improve treatment planning for patients who are having surgery.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.